Carbon nanotubes (CNTs) have emerged as promising nanomaterials with unique properties that hold great potential in the pharmaceutical field. These cylindrical structures, composed of rolled-up graphene sheets, exhibit exceptional mechanical strength, electrical conductivity, and a high surface area, making them versatile candidates for various applications. In the realm of pharmaceuticals, carbon nanotubes offer novel opportunities for drug delivery systems, diagnostic imaging, and therapeutic interventions. Their hollow structures can be utilized to encapsulate drugs, protecting them from degradation and facilitating controlled release. Furthermore, the high aspect ratio and surface functionalization potential of CNTs enable targeted drug delivery to specific cells or tissues, minimizing off-target effects.
Carbon nanotubes also exhibit excellent biocompatibility and can be engineered to carry diagnostic agents for imaging purposes, aiding in the early detection of diseases. Additionally, their unique electronic properties have led to advancements in biosensor development, offering sensitive and rapid detection of biomolecules. Despite the significant promise, challenges such as biocompatibility, toxicity, and large-scale production need to be addressed to fully harness the potential of carbon nanotubes in the pharmaceutical field. Ongoing research continues to explore and optimize the applications of CNTs, paving the way for innovative solutions in drug delivery and diagnostics.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia